BIO-TECHNE Corp (TECH) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-29 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BIO-TECHNE Corp (TECH) CIK: 0000842023 --- Reporting Owner --- Name: Hippel James CIK: 0001603594 Role: Officer (CFO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-29 | Code: M (Exercise of derivative) Shares: +62,068 | Price: $47.60 Total Value: $2,954,436.80 Shares Owned After: 215,738 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-07-29 | Code: F (Payment of exercise/tax) Shares: -51,024 | Price: $72.03 Total Value: $3,675,258.72 Shares Owned After: 164,714 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Stock Options (Right to Buy) Date: 2026-07-29 | Code: M (Exercise of derivative) Shares: -62,068 | Price: $0.00 Exercisable: N/A | Expires: 2026-08-07 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] Fully exercisable. --- Holdings --- [Holding #1] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F1] Fully exercisable. [Holding #2] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F1] Fully exercisable. [Holding #3] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F3] Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. [Holding #4] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. [F4] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F4] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #5] Security: Performance Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F4] Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #6] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F5] Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. [Holding #7] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. [F6] Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F6] Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #8] Security: Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. [F7] 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. [F7] 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. [Holding #9] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F8] Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. [Holding #10] Security: Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. [F9] 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. [F9] 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. [Holding #11] Security: Performance Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. [F10] Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [F10] Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). [Holding #12] Security: Restricted Stock Units Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. [F11] 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. [F11] 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. [Holding #13] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F12] Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. --- Footnotes (Complete Index) --- F1: Fully exercisable. F10: Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11: 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12: Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3: Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. F4: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F5: Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7: 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8: Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9: 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. --- Signature --- /s/ /s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed (2026-07-31)